2024-09-16 - Analysis Report
## AMGN Stock Analysis Report

**Company Overview:** AMGN (Amgen Inc.) is a leading biotechnology company focused on the development and manufacturing of human therapeutics. 

**Performance:**

* **Cumulative Returns:** AMGN has delivered a cumulative return of **57.69%**, trailing the S&P 500 (VOO) return of **88.73%**. 
* **Relative Performance:** The stock currently lags behind the S&P 500 by **-31.04%**, placing it at **46.13%** of its historical range of performance against the benchmark.
* **Recent Price Movements:** AMGN's closing price is **$332.45**. The 5-day, 20-day, and 60-day moving averages are **$329.47, $328.09, and $325.20** respectively, indicating a slightly upward trend in the short term.

**Technical Indicators:**

* **RSI:** The RSI value of **55.29** suggests that the stock is currently in a neutral territory, neither overbought nor oversold.
* **PPO:** The PPO value of **0.07** indicates a slight positive momentum, suggesting potential for further growth.
* **Delta_Previous_Relative_Divergence:** The recent 20-day change of **0.65** suggests a **short-term upward trend**.
* **Expected_Return:** The expected return is **7.59%**, indicating a potential maximum return of 7.59% for a 5-year investment.

**Recent Earnings and Outlook:**

* **Earnings Overview:** AMGN recently reported earnings of **$1.39 per share** on revenue of **$8.39 Billion** for the quarter ending August 7, 2024. 
* **Comparison with Estimates:**  No information on analysts' estimates was provided.  Please provide earnings estimates for a more comprehensive analysis.
* **Trend Analysis:** The recent earnings trend demonstrates a generally stable performance with a notable decline in the quarter ending May 3, 2024. This could suggest cyclical factors impacting the company's revenue. Further investigation is needed to understand the underlying causes for this decline.

**Summary:**

Overall, AMGN's performance has trailed the S&P 500 over the given period, although it currently shows a positive short-term trend. Technical indicators are neutral to slightly positive, indicating potential for further growth. The recent earnings report shows a stable performance with a recent dip.  Further analysis of analyst estimates and potential factors impacting the company's revenue will be needed to provide a more complete picture of AMGN's prospects. 
